RDHL stock Statistics — RedHill Biopharma Ltd. filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstanding: —
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interest: —
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 14.40%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 52.00%
Avg volume (10D): Sign in
Avg volume (3 months)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Cash & equivalentsas of Dec 25: $3.97M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Dec 25: $1.07M
Debt / equityas of Dec 25: 25.07%
Current ratioas of Dec 25: 0.34
Quick ratio: —
Operating cash flowFY Dec 25: -$9.65M
Free cash flowUnadjusted FCF = CFO − capex · FY Dec 25: -$9.65M
TTM revenue / diluted share: —